Tumour Vascular Disrupting Agent

Related by string. * Tumours . TUMOUR : Tumour Necrosis Factor . Tumour VDA . Brain Tumour Foundation / VASCULAR . vascular : cardio vascular . Cardio Vascular . peripheral vascular disease / Disrupts . Disrupted . disrupts : endocrine disrupting compounds . vascular disrupting agent . rainforests disrupt / agenting . AGENT . Agents : agent Scott Boras . Border Patrol agents . Border Patrol agent * *

Related by context. Frequent words. (Click for all words.) 69 vascular disrupting agent 69 Panzem R 68 Initiates Phase II 68 JAK1 67 proteasome inhibitor 67 orally bioavailable 67 liposomal formulation 67 AEG# 66 humanized anti 66 Factor VIIa 66 Presents Positive 66 refractory chronic lymphocytic 66 humanized monoclonal antibody 65 CD# expressing 65 targeting CD# 65 multi kinase inhibitor 65 MEK inhibitor 65 MKC# 65 Thiarabine 65 drug conjugate 65 tyrosine kinase inhibitor 65 Onalta 65 Receives Orphan Drug Designation 65 Drug Candidate 65 ALN TTR 65 R sorafenib tablets 64 novel RNAi therapeutics 64 HGS ETR2 64 CCX# 64 CD# antibody [001] 64 anticancer compound 64 IMC #B 64 CYC# 64 Metastatic Melanoma 64 polymerase inhibitor 64 Cetrorelix 64 Inc. Nasdaq IMGN 64 Proxinium TM 64 humanized antibody 64 TLR9 agonist 64 novel orally administered 64 anticancer compounds 64 SGLT2 63 ATL# [001] 63 Ofatumumab 63 Mipomersen 63 Voreloxin 63 Nanobody 63 advanced carcinoid 63 ThermoDox R 63 novel antibody therapeutics 63 Vandetanib 63 CORT # 63 ALN VSP 63 Dasatinib 63 therapeutic monoclonal antibodies 63 ALN TTR# 63 Azedra 63 BZL# 63 Daclizumab 63 phase IIb clinical 63 Commences Phase 63 Preclinical Data 63 Phase III Clinical Trial 63 Carfilzomib 63 Bavituximab 63 partial agonist 63 Initiate Phase 63 Epratuzumab 63 poly ADP ribose polymerase 63 angiogenesis inhibitor 62 pertuzumab 62 TELINTRA 62 Microplasmin 62 II Clinical Trial 62 Completes Enrollment 62 Pivotal Phase III 62 immune modulator 62 antisense drug 62 induces apoptosis 62 personalized immunotherapy 62 proteasome inhibitors 62 oncolytic viruses 62 CA4P 62 oncolytic 62 Locteron ® 62 deforolimus 62 Aliskiren 62 Tesetaxel 62 PEGylated 62 Monoclonal Antibody 62 FGFR 62 CR# vcMMAE 62 immunomodulating 62 Aurora kinase 62 R bortezomib 62 PEG SN# 62 B lymphocyte stimulator 62 Pralatrexate 62 epothilone 62 potent inhibitor

Back to home page